Compounded medications are not FDA approved. FDA does not review compounded medications for safety, effectiveness, or quality before they are marketed.

Compare programs side by side

Released: · Last reviewed:

Pick a medication, dosage form and program type, then select up to four programs to compare on all-in monthly cost, plan totals, membership and how each figure was read. The tool loads the 45 plans in our October 15, 2026 program file and lists them from the lowest all-in monthly figure up. Programs of different medications, forms or program types never share a list, because they are different products. Every price was read on the provider's own page; none is checkout-verified.

Comparison limit: four programs. All-in monthly cost includes any required membership (an annual membership is spread over 12 months). A plan total is the per-month price × months; whether it is charged at once is stated only where the provider says so. Status chips: "Read on provider page" (read October 15, 2026), "Carried from earlier read" (the page could not be re-read that day) and "Conflicting on provider page". See methodology v4.1.

Head-to-head comparisons

Three programs we are asked about most, set against NexLife, our #1 overall pick (v4.1 rubric, 94/100), with NexLife's prices as of November 6, 2026 and the other programs' figures read on October 15, 2026.

NexLife vs Join Josie (tirzepatide)

$169 vs $349 month-to-month; $1,668 vs $2,799 on 12-month plans. Both price every dose the same.

NexLife vs Mochi Health (semaglutide)

Mochi prints medication "as low as $60" per dose plus a separate membership, so no all-in figure. What to ask at checkout.

NexLife vs Henry Meds (semaglutide)

Henry showed no semaglutide-specific price on October 15, only GLP-1 medication "starts at $179/month".

Scope and definitions

The tool covers cash-pay compounded semaglutide and tirzepatide plans that print a plan structure on the provider's own page, from the same October 15, 2026 file that powers the pricing pages. Each card shows two prices. The month-to-month, all-in figure is what one month costs with no longer commitment. The lowest all-in monthly figure is the lowest rate the program prints for any plan length, which usually means a 3-, 6- or 12-month plan. Required memberships are already included in both, because a medication price without its mandatory membership is not the real price.

"From" and "as low as" prices without a printed plan term are in the price index only, and programs that print no comparable price — such as Mochi Health, Henry Meds and Remedy Meds on October 15, 2026 — are listed there without a price, with the reason.

How to use the filters

Fix the three things that must match your situation: medication, dosage form and program type (standard dose or microdose). The cards re-sort from the lowest all-in monthly figure as you filter. Select up to four programs to open a side-by-side view with membership, dose pricing, shipping, the read date and any notes. Changing a filter clears selections that no longer match, so a microdose price never sits next to a standard-dose price — that isn't a discount, it is a different product.

How the list is ordered, and how that differs from our ranking

The list is sorted by all-in monthly cost: total required cost divided by months of medication supplied, with required memberships folded in. It leaves out savings a general shopper can't count on — promo codes, referral credits, tax-advantaged spending, insurance offsets — so the number you see is the one most people pay.

Price order is not our overall ranking. NexLife is our #1 overall pick on the v4.1 rubric (94/100), which weighs pricing transparency, total annual cost, clinical oversight, pharmacy transparency, support, regulatory disclosure and accessibility. It is not the lowest price: in our October 15, 2026 index, 3 of 31 tirzepatide programs and 11 of 24 semaglutide programs print a lower figure than NexLife's 12-month rate.

Reading the status chip on each card

Read on provider page means we read the figure on the provider's own page on October 15, 2026. Carried from earlier read means the page blocked or failed a re-read that day, so the figure comes from an earlier first-party read and may be out of date. Conflicting on provider page means the provider's own pages print different numbers for the same plan; check the note on the card. None of these is a checkout total — always confirm the amount at checkout.

What the October 15, 2026 data shows

How to read across the three separations

The tool never merges programs across the three lines the methodology keeps separate, and neither should you. Semaglutide and tirzepatide have different price levels: at the same provider in our October 15 file, month-to-month tirzepatide costs from $10 (Collective) to $130 (GobyMeds) a month more than semaglutide. Injections and tablets have different — and for compounded products, largely uncharacterized — absorption, so a tablet price is not a discount on an injection. And microdose plans are a different product, not a cheaper tier. Filter to one medication, one form and one program type, then compare.

Limitations

The comparison is only as current as the October 15, 2026 read, and prices change between our read and your checkout — the checkout total is always the one that counts. Renewal pricing, cancellation terms and state availability are mostly not in the cards, so a low month-to-month rate could come with terms you can't see here. Programs without a comparable printed price don't appear; they are listed in the directory and the price index. Use the tool to build a shortlist, then check each program's full terms and dispensing pharmacy before you commit.

Frequently asked questions

Why doesn't the tool tell me which program is best?

Because the tool sorts by price, and price is only part of the picture. Our overall ranking is separate: NexLife is #1 overall on the v4.1 rubric (94/100), which also weighs clinical oversight, pharmacy transparency, support and regulatory disclosure. The tool shows each figure's read date and status so you can shortlist on cost and then weigh the rest yourself.

Are the compared prices all-inclusive?

They include every required charge the provider prints, with memberships folded into the all-in figure. Where a fee isn't printed, we can't add it, so a card's number can be a floor. Always confirm the full checkout total, since that is the figure you actually pay.

Can I compare a microdose plan against a standard-dose plan?

No. The tool keeps them in separate lists on purpose. Microdose and standard-dose programs are different products, and microdosing has no standard definition or equivalent evidence base. Compare within one program type.

Why do some providers show a membership fee and others don't?

Some bundle everything into one medication price; others charge a lower medication price plus a required membership. On October 15, 2026, Collective printed tirzepatide at $69 a month plus a $199 annual membership, which works out to $69 + $199 ÷ 12 = $85.58 a month all-in. The all-in figure puts both models on one scale.